Ozempic, las inyecciones que prometen acabar con la obesidad y que arrasan en el mercado negro | Salud y bienestar | EL PAÍS
![Novo Nordisk amplía investigación en nuevas tecnologías de administración de medicamentos biológicos - enFarma Novo Nordisk amplía investigación en nuevas tecnologías de administración de medicamentos biológicos - enFarma](https://enfarma.lat/images/noticias/2022-03/nordisk.jpg)
Novo Nordisk amplía investigación en nuevas tecnologías de administración de medicamentos biológicos - enFarma
![Novo Nordisk obtiene aprobación de la FDA para Rybelsus como tratamiento de diabetes tipo 2. - Ignición Farma Novo Nordisk obtiene aprobación de la FDA para Rybelsus como tratamiento de diabetes tipo 2. - Ignición Farma](https://ignicionfarma.com/wp-content/uploads/2019/09/novo-nordisk-diabetes-1024x591.jpg)
Novo Nordisk obtiene aprobación de la FDA para Rybelsus como tratamiento de diabetes tipo 2. - Ignición Farma
El grupo biotecnológico Ablynx rechaza la oferta de compra de Novo Nordisk por 3.100 millones de dólares | Reuters
![A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy](https://c8.alamy.com/comp/2EMJ0GD/a-package-of-victoza-liraglutide-injectors-manufactured-by-novo-nordisk-prescription-pharmaceuticals-photographed-in-a-pharmacy-in-remington-virginia-on-february-26-2019-photo-by-kristoffer-tripplaarsipa-usa-2EMJ0GD.jpg)
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
![Novo Nordisk Stock Notches Another Record As Obesity Treatments Spark Sales, Profits | Investor's Business Daily Novo Nordisk Stock Notches Another Record As Obesity Treatments Spark Sales, Profits | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2023/04/Stock-novonordisk-vials-01-adobe.jpg)
Novo Nordisk Stock Notches Another Record As Obesity Treatments Spark Sales, Profits | Investor's Business Daily
![Novo Nordisk Launches Rebinyn in the U.S. for People with Hemophilia B | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Novo Nordisk Launches Rebinyn in the U.S. for People with Hemophilia B | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/346973-333x250.jpg)
Novo Nordisk Launches Rebinyn in the U.S. for People with Hemophilia B | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy in Remington, Virginia, on February 26, 2019. (Photo by Kristoffer Tripplaar/Sipa USA Stock Photo - Alamy A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy in Remington, Virginia, on February 26, 2019. (Photo by Kristoffer Tripplaar/Sipa USA Stock Photo - Alamy](https://c8.alamy.com/comp/2EMJ0FC/a-package-of-victoza-liraglutide-injectors-manufactured-by-novo-nordisk-prescription-pharmaceuticals-photographed-in-a-pharmacy-in-remington-virginia-on-february-26-2019-photo-by-kristoffer-tripplaarsipa-usa-2EMJ0FC.jpg)